Piotr Thor
Overview
Explore the profile of Piotr Thor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zygulska A, Furgala A, Krzemieniecki K, Wlodarczyk B, Thor P
Adv Med Sci
. 2018 Nov;
64(1):44-53.
PMID: 30469053
Purpose: Dyspeptic symptoms present a severe problem in gastrointestinal (GI) cancer patients. The aim of the study was to analyze an association between gastric myoelectric activity changes and dyspeptic symptoms...
2.
Zygulska A, Furgala A, Krzemieniecki K, Wlodarczyk B, Thor P
Cancer Invest
. 2018 Jun;
36(5):255-263.
PMID: 29953262
To the best of our knowledge, only two studies analyzed the relationship between HRV and carcinoembryonic antigen (CEA) in colon cancer patients. The aim of this study was to analyze...
3.
Dobrek L, Skowron B, Baranowska A, Malska-Wozniak A, Thor P
Przegl Lek
. 2018 Apr;
73(11):805-12.
PMID: 29693342
Introduction: Oxazaphosphorine
agents (cyclophosphamide - CP,
ifosfamide - IF) are causative factors
of cystitis and also exert a characteristic
nephrotoxic effect, clinically
manifested by a broad spectrum of
disturbances.
The...
4.
Dobrek L, Skowron B, Baranowska A, Ploszaj K, Badziul D, Thor P
Medicina (Kaunas)
. 2017 Jul;
53(3):179-189.
PMID: 28720209
Background And Objective: The application of cytostatic oxazaphosphorines such as cyclophosphamide (CP) and ifosfamide (IF) is associated with the risk of kidney damage that, depending on the type of drug,...
5.
Kurnik-Lucka M, Gil K, Bugajski A, Furgala A, Thor P
Neuro Endocrinol Lett
. 2017 Mar;
37(7):501-510.
PMID: 28326744
Objectives: Previous studies have reported that exogenous salsolinol might contribute to myenteric cell death and altered gastrointestinal motility. Because the entire gut mucosal, entero-endocrine and motor functions are integrated by...
6.
Ciesielczyk K, Furgala A, Dobrek L, Juszczak K, Thor P
Arch Med Sci
. 2017 Feb;
13(1):246-255.
PMID: 28144278
Introduction: Pain hypersensitivity, abnormal motility and autonomic dysfunction contribute to functional symptoms of inflammatory bowel disease (IBD). Material And Methods: The aim of this study was to assess: nociceptive thresholds...
7.
Przybylska-Felus M, Furgala A, Kaszuba-Zwoinska J, Thor P, Mach T, Zwolinska-Wcislo M
Folia Med Cracov
. 2016 Dec;
56(2):56-72.
PMID: 28013323
Background/aims: The aim of the study was to analyze the effect of celiac disease(CED) on the upper-gut motility and release of enteral hormones (ghrelin and pancreatic peptide (PP)). Materials And...
8.
Aleksandrovych V, Kurnik M, Bialas M, Bugajski A, Thor P, Gil K
Folia Med Cracov
. 2016 Aug;
56(1):81-95.
PMID: 27513841
Salsolinol (1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline) is thought to regulate dopaminergic neurons and to act as a mediator in the neuroendocrine system. We have previously reported that exogenous salsolinol evokes enteric neuronal cell death,...
9.
Balajewicz-Nowak M, Furgala A, Pitynski K, Thor P, Huras H, Rytlewski K
Neuro Endocrinol Lett
. 2016 Mar;
37(1):70-7.
PMID: 26994389
Objective: The purpose of this research was to assess the dynamics of autonomic nervous system(ANS) and hemodynamic activity changes during uncomplicated pregnancy. Methods: We enrolled 36 pregnant women (mean age...
10.
Krygowska-Wajs A, Furgala A, Gorecka-Mazur A, Pietraszko W, Thor P, Potasz-Kulikowska K, et al.
Parkinsonism Relat Disord
. 2016 Mar;
26:35-40.
PMID: 26952698
Objective: Deep brain stimulation of the subthalamic nucleus (STN-DBS) is well established for treating the motor symptoms for advanced Parkinson's disease (PD) but its effects on gastric myoelectrical activity and...